EP
IDXX icon

Essential Partners’s Idexx Laboratories IDXX Stock Holding History

Essential Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Sell
78
-373
-83% -$209K 0.02% 664
2026
Q1 		$253K Sell
451
-7
-2% -$4.49K 0.09% 254
2025
Q4 		$310K Buy
458
+1
+0.2% +$681 0.1% 248
2025
Q3 		$292K Buy
457
+6
+1% +$3.64K 0.1% 251
2025
Q2 		$242K Buy
+451
New +$216K 0.1% 255

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Essential Partners's IDXX Position: Q2 2026 in Review

Essential Partners reduced its Idexx Laboratories (IDXX) stake by 83% in Q2 2026, selling an estimated $209K and leaving 78 shares worth $41.1K. The position accounts for 0.02% of the portfolio, ranked #664.

Essential Partners first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $310K in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Essential Partners held 78 shares of Idexx Laboratories worth $41.1K as of Q2 2026.
  • Essential Partners sold 373 Idexx Laboratories shares in Q2 2026, an estimated $209K.
  • Idexx Laboratories made up 0.02% of Essential Partners's portfolio in Q2 2026, its #664 holding.
  • Essential Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Idexx Laboratories position peaked at $310K in Q4 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.